Crinetics Pharmaceuticals
CRNX
CRNX
235 hedge funds and large institutions have $4.32B invested in Crinetics Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 97 increasing their positions, 74 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 234 → 235 (+1)
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
30% less call options, than puts
Call options by funds: $1.6M | Put options by funds: $2.28M
Holders
235
Holding in Top 10
12
Calls
$1.6M
Puts
$2.28M
Top Buyers
| 1 | +$91.5M | |
| 2 | +$34.3M | |
| 3 | +$31.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$27.8M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$27.3M |
Top Sellers
| 1 | -$47.7M | |
| 2 | -$38.8M | |
| 3 | -$24.8M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$19.1M |
| 5 |
SC
Stempoint Capital
New York
|
-$17.4M |